Targeting triglycerides for cardiovascular risk reduction

Carlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, Laura D’Erasmo · 2026

Read Targeting triglycerides for cardiovascular risk reduction by Carlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, Laura D’Erasmo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13582088.txt.

Description

Carlo Maiorca and co-authors review triglycerides as a target for cutting heart risk in a 2026 paper. Many patients still face heart attacks even when cholesterol, blood pressure, and blood sugar are well controlled. Triglycerides are blood fats, and the particles that carry them can drive artery clogging. The review weighs the proof that lowering them helps.

Those fat-rich particles inflame artery walls and favor clots, and genetic studies back their causal role. Older drugs, such as fibrates and mixed fish oils, gave modest and uneven gains in trials. One purified fish oil drug cut major heart events in a large trial, whatever the starting fat level. Newer agents, an antibody and several gene-silencing drugs, slash the fats sharply in early studies. Their effect on heart events is not yet known. The authors see the path as promising for high-risk patients.

Catalog record

CREATORCarlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, Laura D’Erasmo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13582088

Browse the full library · About the Tower of Babel